2020
DOI: 10.1080/09638288.2020.1800837
|View full text |Cite
|
Sign up to set email alerts
|

Acute and subacute hemodynamic responses and perception of effort in subjects with chronic Chagas cardiomyopathy submitted to different protocols of inspiratory muscle training: a cross-over trial

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 30 publications
0
3
0
Order By: Relevance
“…Currently, a total of 30 papers have studied the IMT effects in HF patients [ 28 , 39 , 40 , 44 , 61 , 62 , 63 , 64 , 65 , 66 , 67 , 68 , 69 , 70 , 71 , 72 , 73 , 74 , 75 , 76 , 77 , 78 , 79 , 80 , 81 , 82 , 83 , 84 , 85 , 86 ]. From these 30 studies, only 5 studies [ 28 , 66 , 67 , 74 , 85 ] analyzed the IMT effects on respiratory muscle metaboreflex.…”
Section: Resultsmentioning
confidence: 99%
“…Currently, a total of 30 papers have studied the IMT effects in HF patients [ 28 , 39 , 40 , 44 , 61 , 62 , 63 , 64 , 65 , 66 , 67 , 68 , 69 , 70 , 71 , 72 , 73 , 74 , 75 , 76 , 77 , 78 , 79 , 80 , 81 , 82 , 83 , 84 , 85 , 86 ]. From these 30 studies, only 5 studies [ 28 , 66 , 67 , 74 , 85 ] analyzed the IMT effects on respiratory muscle metaboreflex.…”
Section: Resultsmentioning
confidence: 99%
“…In addition to low aerobic capacity and peripheral muscle weakness, inspiratory muscle weakness is estimated in 30% to 50% of patients with CHD[ 107 ]. Inspiratory muscle training (IMT) alone and associated with aerobic training[ 108 , 109 ] may improve exercise capacity in HF patients by reducing diaphragmatic metaboreflex activity and respiratory muscle fatigue[ 110 ].…”
Section: Non-pharmacological Strategiesmentioning
confidence: 99%
“…Despite the growing recommendation of IMT to become a part of CR, little is known about this strategy for CHD. Recently, two IMT protocols (30% and 60% of MIP) have been safely tested in patients with CHD[ 107 ].…”
Section: Non-pharmacological Strategiesmentioning
confidence: 99%